T-Cell and NK-Cell Neoplasm — Trials

T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,103 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–24 of 24 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02943642	Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides(Resimmune®)	withdrawn	Phase 2	0	Virogen Biotechnology Inc.INDUSTRY	0	May 18, 2026	clinicaltrials
NCT07585734	Clinical Trial of CD38 Monoclonal Antibody Combined With Chemotherapy for T-Cell Acute Lymphoblastic Leukemia	withdrawn	Phase 1 / Phase 2	0	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	0